MD Anderson Cancer Center
Low forms of Cyclin E reduces drug's effectiveness

M. D. Anderson researchers find better way to predict prognosis in breast cancer patients treated with aromatase inhibitors; research also suggests a potential means of circumventing drug resistance
Video is loading...
Title: Low forms of Cyclin E reduces drug's effectiveness
Summary: M. D. Anderson researchers find better way to predict prognosis in breast cancer patients treated with aromatase inhibitors; research also suggests a potential means of circumventing drug resistance
Keywords: breast, cancer, cyclin e, aromatase inhibitor, drug resistance, Keyomarsi, MD Anderson, estrogen-receptor–positive, er+, low-molecular-weight, LMW-E
Transcript: